Close Menu

NHGRI

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.

Researchers identified a new type 2 diabetes-associated site involving the ZRANB3 gene, which may have a role in regulating pancreatic beta cells.

The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.

The initiative, funded in partnership with NHGRI and Color, will mentor 40 trainees through a competitive process and host programs to encourage diversity.

The Telomere-to-Telomere consortium has already generated a gapless assembly of the human X chromosome and aims to complete all chromosomes over the next two years or so.

The Human Genome Reference Program aims to build a human genome reference that better accounts for genetic diversity than the existing reference.

A new analysis pointed to a rise in over-generalized or incorrect bacterial identification by k-mer lowest common ancestor methods as the database has grown.

Investigators reported on efforts to help labs better implement guidelines and measure disease associations, and to create shared languages for variants across different databases.

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.